91 related articles for article (PubMed ID: 2389953)
1. [Effect of intrapleural and/or intraperitoneal lentinan therapy in carcinomatous pleuritis and peritonitis].
Yoshino S; Oka M; Hazama S; Suzuki T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1588-91. PubMed ID: 2389953
[TBL] [Abstract][Full Text] [Related]
2. [Effect of intrapleural and/or intraperitoneal lentinan therapy on carcinomatous pleuritis and peritonitis with special reference to immunological evaluation].
Yoshino S; Oka M; Hazama S; Suzuki T
Nihon Geka Hokan; 1989 May; 58(3):310-9. PubMed ID: 2619436
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
4. [Immunochemotherapy of carcinomatous peritonitis and pleuritis--report of 2 cases].
Takekoshi H; Yoshida K; Morinaga S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1466-9. PubMed ID: 1326910
[TBL] [Abstract][Full Text] [Related]
5. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
6. [Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].
Inagaki T; Morise K; Matsunaga H
Gan To Kagaku Ryoho; 1988 Feb; 15(2):319-24. PubMed ID: 3257678
[TBL] [Abstract][Full Text] [Related]
7. [NK activity and T cell subsets in percutaneous ethanol injection therapy of liver cancer--effect of lentinan with combined use].
Yamamoto S; Takatori K; Ohmoto K; Ideguchi S; Yamamoto R; Ohumi T; Hino K; Hirano Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3291-4. PubMed ID: 2551254
[No Abstract] [Full Text] [Related]
8. Immunological analysis and clinical effects of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion.
Oka M; Yoshino S; Hazama S; Shimoda K; Suzuki T
Biotherapy; 1992; 5(2):107-12. PubMed ID: 1524950
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of the combination treatment of intrapleural or intraperitoneal administration of lentinan and OK-432 for malignant effusion].
Yoshino S; Yoshida S; Maeda N; Maeda Y; Maeda K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2798-800. PubMed ID: 21224717
[TBL] [Abstract][Full Text] [Related]
11. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
[TBL] [Abstract][Full Text] [Related]
12. [Studies on usefulness of postoperative adjuvant chemotherapy with lentinan in patients with gastrointestinal cancer].
Tanabe H; Imai N; Takechi K
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1657-67. PubMed ID: 2230448
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients].
Amino M; Noguchi R; Yata J; Matsumura J; Hirayama R; Abe O; Enomoto K; Asato Y
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2000-6. PubMed ID: 6225393
[TBL] [Abstract][Full Text] [Related]
15. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
16. Lentinan potentiates immunity and prolongs the survival time of some patients.
Matsuoka H; Seo Y; Wakasugi H; Saito T; Tomoda H
Anticancer Res; 1997; 17(4A):2751-5. PubMed ID: 9252710
[TBL] [Abstract][Full Text] [Related]
17. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for patients with carcinomatous pleuritis.
Ohta Y; Shimizu Y; Matsumoto I; Watanabe G
J Exp Clin Cancer Res; 2006 Mar; 25(1):15-9. PubMed ID: 16761613
[TBL] [Abstract][Full Text] [Related]
18. [Results of phase III study of lentinan].
Taguchi T; Furue H; Kimura T; Kondo T; Hattori T; Itoh I; Ogawa N
Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Sugiyama Y; Saji S; Furuta T; Azuma S; Miya K; Umemoto T; Takao H; Kato M; Kanno A
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1724-7. PubMed ID: 1530341
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity.
Amirghofran Z; Sheikhi AK; Kumar PV; Saberi Firouzi M
J Cancer Res Clin Oncol; 2002 Aug; 128(8):443-8. PubMed ID: 12200601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
